CORIODERMINA

Coriodermina is a placental factor that inhibits the development of psoriatic crisis regulating the speed of the epidermic cells' reproduction or queratinocites, through the neutralization of the stimulating effect of various quimical mediators of the inflammatory process, such as neurepeptides and cytokinas. It is presented in form of a hydrosoluble jelly which acts in the dermic layer by transcutaneous adsorption from the site of application.
It is innocuous and may be used in both children and adults of all ages, expectant mothers, and during menstruation.
It is compatible with all kinds of food, beverages, and other drugs. CORIODERMINA has no harmful local or systemic side effects.

WARNING

At the beginning of treatment, gel application on psoriatic areas may produce a reactivation o crises in 30 % of the patients, characterized by a marked reddening of the plaques and an intensification of prurience and scaling, as well as an increase in the thickness and number of plaques.

This effect lasts approximately 15 to 25 days; then symptom gradually disappear until lesions, prurience and scaling all totally eliminated in 30 to 60 days.

DOSAGE

Apply Coriodermina with the finger all over psoriatic lesions [plaques],spreading in gently,three times a day every 8 hours. Do not rub.

After every application,do nor cover treated areas with clothing for 30-40 minutes to facilitate proper dermal penetration. Every day after one of the three applications,expose treated areas for 30 minutes to a 150-250 watt infrarred lamp,placed at a distance of 40 cms.Avoid looking directly into the light as it can cause vision disturbances.

PACKAGING

200 g. plastic flask.

COMPOSITION

Every 100 g. contains:

Human placental fraction WITH bioactivating action on the conversion process of the epidermal cells solubilized in ethanol (90 degrees), 50 ml.

Hydrosoluble excipient, 100 g.